Compare NGL & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGL | DRTS |
|---|---|---|
| Founded | 1940 | 2015 |
| Country | United States | Israel |
| Employees | 569 | N/A |
| Industry | Natural Gas Distribution | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 607.1M |
| IPO Year | N/A | N/A |
| Metric | NGL | DRTS |
|---|---|---|
| Price | $12.00 | $8.42 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | ★ 420.8K | 281.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $366.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.64 | $2.30 |
| 52 Week High | $13.00 | $7.89 |
| Indicator | NGL | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 60.84 | 67.12 |
| Support Level | $9.30 | $6.57 |
| Resistance Level | $13.00 | N/A |
| Average True Range (ATR) | 0.44 | 0.50 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 55.75 | 97.17 |
NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.